Navigation Links
Better prostate cancer detection,,

Recently a more extensive biopsy detecting technique for prostate cancers has been found out by researchers.

This is very effective than the traditional examination. In the traditional exam for prostate cancer, the doctor takes six tissue samples from the prostate gland.

At Ohio State University, researchers said that it is better to take more samples.//

Dr.Robert Bahnson and his team, called this the extended sector biopsy.

They took 12 samples - six from the outer rim of the prostate and six more from the inside of the gland. They did this on a group of 74 men and found cancer in 40 of them. In ten, the cancer was found only in one or more of the six inner areas - and would have been missed if the conventional method was used.

Dr Bahnson routinely uses the extended biopsy now. An added bonus of this technique is that it saves certain patients from having to come back for a second biopsy - when the first is clear but cancer is still suspected.


'"/>




Page: 1

Related medicine news :

1. Better Treatment for obesity
2. For a Better Memory
3. Baby Talk Better Than Adult Speech
4. Drug Combo Works Better for children with ADHD, Tics
5. Better skin with lasers
6. Better diabetes treatment promises Vanadium
7. Better Prostate Cancer Test
8. Better Drug for Heart Transplant
9. Better Diet Even Late in Life May Prolong It
10. Better Care Required for Breast Cancer Survivors
11. Two drugs Mays Be Better Than One For Prostate Enlargement
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Better prostate cancer detection

(Date:7/29/2014)... is here down under, and it seemed like just ... That is, until a troop of men and women ... into a celebration—a celebration of drug-free living. , The ... About Drugs, a drug prevention initiative supported by the ... city with a rousing performance of Maori song and ...
(Date:7/29/2014)... July 29, 2014 Parker Waichman LLP, ... of victims injured by defective drugs and medical devices, ... by plaintiffs in Canada who allege that they were ... with the low testosterone injection Delatestryl (Court File ... 2014 in the Ontario Superior Court of Justice. , ...
(Date:7/29/2014)... WA, Australia (PRWEB) July 30, 2014 ... regulation of medical devices have determined Nurse Call ... and international legislation, this requires all Nurse Call ... This regulatory practice improves patient safety, reduces clinical ... and private hospital based Corporate Risk and Clinical ...
(Date:7/29/2014)... DailyGossip.org reveals in its latest review that the ... perfectly understand patients and what they have to go through ... the author of the new program. Ellie claims that she ... Ellie started her very own research. Four years passed until ... of the Get Rid of Cold Sores program claims that ...
(Date:7/29/2014)... Denver, Colorado (PRWEB) July 29, 2014 Daily ... is a powerful and holistic system that will teach users ... been tried by thousands of people, from all over the ... of the symptoms of this disorder in as quickly as ... will be gone faster than imagined. , The Fibroids ...
Breaking Medicine News(10 mins):Health News:Sydney Business District “Rocked” by The Truth About Drugs 2Health News:Class Action Lawsuit in Canada Alleges Manufacturer of Delatestryl Testosterone Injection Failed to Warn of Cardiovascular Risks, Parker Waichman LLP Reports 2Health News:Class Action Lawsuit in Canada Alleges Manufacturer of Delatestryl Testosterone Injection Failed to Warn of Cardiovascular Risks, Parker Waichman LLP Reports 3Health News:NiQ Health Reveals the Extensive Use of Unregulated Medical Devices in Australian Hospitals 2Health News:NiQ Health Reveals the Extensive Use of Unregulated Medical Devices in Australian Hospitals 3Health News:NiQ Health Reveals the Extensive Use of Unregulated Medical Devices in Australian Hospitals 4Health News:Get Rid of Cold Sores Fast Review Exposes the Way to Stop Outbreaks 2Health News:Amanda Leto’s Fibroids Miracle Review Reveals Clinically Proven Uterine Fibroids Cure System 2
... state that there are insufficient doctors specializing in sports medicine ... Olympics// that is to be hosted by UK. ,Presently ... specialist each, for the treatment of treat sports injuries as ... ,According to the Royal College of Physicians specialists ...
... the American Red Cross yet again with a whopping fine ... blood collection techniques.// The Red Cross (ARC), which is responsible ... has been under the vigilance of the government since 1993, ... enhancing the quality control system., ,This fine slapped ...
... Cocaine, in concentrations commonly sold on the street, causes ... – a process causing heart enlargement that can ultimately ... of South Florida College of Medicine and James A. ... in the July 2006 issue of the Journal of ...
... genetics of a potentially lethal heart rhythm defect that ... have greatly narrowed //the hunt for the specific genetic ... new findings, described in the July issue of the ... of tests to identify those at risk for arrhythmogenic ...
... increase risk of developing a disability in later life. ... to reduce the nation’s disability levels, // according to ... about risks with exercise, home safety and health assessments ... run, found researchers led by Vicki Freedman, Ph.D., a ...
... the potential to suppress tumor growth also plays a major ... p16INK4a caused cell to grow old and work poorly as ... their age even when transplanted into young mice. Other cells ... older cells. ,Teams from the medical schools at ...
Cached Medicine News:Health News:Sports Doctors too few for 2012 Olympics 2Health News:Researchers Identify Key Step in Cocaine-Induced Heart Enlargement, Sudden Death 2Health News:Closing in on Lethal Heart Rhythm in Young Athletes 2Health News:Closing in on Lethal Heart Rhythm in Young Athletes 3Health News:Preventing Falls May Be Key to Avoiding Disability in Elderly 2Health News:Gene May Regulate Cellular Aging 2Health News:Gene May Regulate Cellular Aging 3
(Date:7/29/2014)... , July 29, 2014 /PRNewswire-iReach/ -- The ... basis of products, methods, applications, end users, and ... growth in the microbial identification market. This favorable ... costs (per test) and the time required for ... continuous technological advancements. Furthermore, genotypic methods have high ...
(Date:7/29/2014)... OAKS, Calif., July 29, 2014 Amgen (NASDAQ: ... the second quarter of 2014. Key results include: ... with 8 percent product sales growth driven by strong ... Kyprolis ® (carfilzomib), Prolia ® (denosumab) and ... 25 percent to $2.37, driven by higher revenues and ...
(Date:7/29/2014)...  Express Scripts Holding Company (Nasdaq: ESRX ... Express Scripts stockholders of $515.2 million, or $0.67 per ... in Table 4, was $1.23 for the second quarter. ... serve our clients with scale, alignment and innovative solutions to ... outcomes of our members," stated George Paz, chairman and chief ...
Breaking Medicine Technology:Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 2Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 3Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 4Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 5Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 6Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 2Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 3Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 4Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 5Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 6Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 7Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 8Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 9Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 10Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 11Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 12Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 13Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 14Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 15Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 16Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 17Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 18Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 19Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 20Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 21Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 22Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 23Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 24Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 25Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 2Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 3Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 4Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 5Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 6Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 7
... Wound Care Innovations, LLC,a subsidiary of Wound ... an evidence based study with a NE podiatric ... care collagen,product, CellerateRx(R), on diabetic venous ulcers. "According ... and Prevention, diabetes now,affects nearly 24 million people ...
... Clinical Program Leverages Quark,s RNAi Technology, FREMONT, ... pharmaceutical company discovering and developing novel,RNA interference (RNAi)-based ... patient dosing in a Phase II trial,evaluating, ... (DME)., PF-4523655 is a novel siRNA drug ...
Cached Medicine Technology:Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers 2Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema 2Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema 3Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema 4
... are available in two tip ... tip with staggered eyes, and ... types of catheter valve options, ... fingertip control with virtually no ...
... are available in two tip ... tip with staggered eyes, and ... types of catheter valve options, ... fingertip control with virtually no ...
Sterile Single Loop Pediatric Suction Catheters with TOUCH-TROL Valve...
Catheter Suction 14FR Sterile W/Control Valve...
Medicine Products: